Skip to main content
Premium Trial:

Request an Annual Quote

Waters' Q3 Results Push Stock Higher

Shares of Waters rose 8.8 percent for the five-day trading period ended Tuesday to lead all stocks in the BCW Index. Its shares rose nearly 9 percent on Tuesday alone after the firm reported 17 percent revenue growth for its third quarter.
 
Caliper Life Sciences and Agilent Technologies led decliners for the tracking period, falling 2.8 percent and 2.5 percent, respectively.
 
Overall, the Index rose 1.2 percent for the week. In comparison, the Dow Jones Industrial Average dropped 1.7 percent, while the Nasdaq climbed 1.3 percent, and the Nasdaq Biotech Index lost .3 percent.
 

BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Closing Price
(Oct. 23, 2007)
Starting Price
(
Oct. 16, 2007)
% change
Affymetrix
AFFX
27.31
26.77
2.02
Agilent
A
37.33
38.3
-2.53
Applied Biosystems
ABI
35.22
35.28
-0.17
Beckman
BEC
73.86
74.02
-0.22
Becton Dickinson
BDX
81.77
82.53
-0.92
Bio-Rad
BIO
95.07
96.24
-1.22
Bruker
BRKR
9.11
8.86
2.82
Caliper
CALP
5.85
6.02
-2.82
Cepheid
CPHD
23.15
22.1
4.75
Illumina
ILMN
62.38
60.32
3.42
Invitrogen
IVGN
84.3
83.05
1.51
Luminex
LMNX
16.33
16.26
0.43
MDS
MDZ
21.96
21.58
1.76
Millipore
MIL
74.5
74.33
0.23
PerkinElmer
PKI
29.5
28.66
2.93
Qiagen
QGEN
21.2
20.79
1.97
Sequenom
SQNM
10.58
9.92
6.65
Sigma-Aldrich
SIAL
50.11
50.73
-1.22
Thermo
TMO
59.51
58.46
1.80
Third Wave
TWTI
9.59
9.37
2.35
Waters
WAT
73.92
67.95
8.79
BCW Index Average  
42.98
42.45
1.23
The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more